FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383105087> ?p ?o ?g. }

• W4383105087 abstract "Introduction Aberrant activation of Extracellular Signal-Regulated Kinase (ERK) signaling is associated with Alzheimer’s disease (AD) pathogenesis. For example, enhanced ERK signal activation mediated by Apolipoprotein E4 (APOE4), which is a critical genetic risk factor for AD, increases the transcription of amyloid precursor protein (APP). We hypothesize that O-linked N-acetylglucosamine (O-GlcNAc) regulates the phosphorylation and activation of ERK. O-GlcNAc is a single sugar post-translational modification that dynamically cycles on and off proteins in response to nutrient changes by the action of the enzymes O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), respectively. However, O-GlcNAc quickly returns to a baseline level after stimulus removal (called O-GlcNAc homeostasis). Methods We did a serum reactivation time-course followed by western blot in SH-SY5Y neuroblastoma cells after long-term O-GlcNAcase (OGA) inhibition by Thiamet-G (TMG) treatment, O-GlcNAc transferase (OGT) knock-down (KD) and OGA KD. Brain tissues of C57BL6/J mice and 5XFAD Alzheimer’s disease mice intra-peritoneally injected with TMG for 1 month and C57BL6/J mice intra-peritoneally injected with TMG for 6 months were also used for western blot. Results We found that ERK1/2 phosphorylation at Thr 202/Tyr204 and Thr183/Tyr185 (p-ERK) are amplified and hence ERK1/2 are activated after long-term OGA inhibition in SH-SY5Y cells. In addition to pharmacological treatment, genetic disruption of O-GlcNAc by OGT KD and OGA KD also increased p-ERK in SH-SY5Y cells suggesting O-GlcNAc homeostasis controls ERK signaling. To determine how O-GlcNAc regulates p-ERK, we probed the expression of phosphorylated mitogen-activated protein kinase-kinase (p-MEK) which phosphorylates and activates ERK and Dual specificity phosphatase-4 (DUSP4) which dephosphorylates and inactivates ERK in SH-SY5Y cells. p-MEK increases in TMG treated and OGT KD cells whereas total DUSP4 decreases in OGT KD and OGA KD cells with serum reactivation time course. Next, we probed the role of OGA inhibition in regulating ERK activation using mice brain-tissue samples. Interestingly, 6-month intra-peritoneal TMG injection in C57BL/6J mice showed an increase in amplitude of p-ERK and APP protein levels, indicating long-term OGA inhibition potentially contributes to AD progression. Furthermore, 1-month TMG injection was sufficient to increase the amplitude of p-ERK in 5XFAD AD mice brains suggesting AD phenotype contributes to the acceleration of ERK activation mediated by OGA inhibition. Conclusion Together, these results indicate that disruptions to O-GlcNAc homeostasis amplify ERK signal activation in AD." @default.
• W4383105087 created "2023-07-05" @default.
• W4383105087 creator A5011494156 @default.
• W4383105087 creator A5012270381 @default.
• W4383105087 creator A5018328570 @default.
• W4383105087 creator A5019154875 @default.
• W4383105087 creator A5023735744 @default.
• W4383105087 creator A5035406667 @default.
• W4383105087 creator A5037022895 @default.
• W4383105087 creator A5037964900 @default.
• W4383105087 creator A5050249978 @default.
• W4383105087 creator A5079568106 @default.
• W4383105087 creator A5092396675 @default.
• W4383105087 creator A5092396676 @default.
• W4383105087 date "2023-07-04" @default.
• W4383105087 modified "2023-10-18" @default.
• W4383105087 title "O-GlcNAcylation regulates extracellular signal-regulated kinase (ERK) activation in Alzheimer’s disease" @default.
• W4383105087 cites W1496314348 @default.
• W4383105087 cites W1794943105 @default.
• W4383105087 cites W2004373930 @default.
• W4383105087 cites W2027899709 @default.
• W4383105087 cites W2028224445 @default.
• W4383105087 cites W2040714286 @default.
• W4383105087 cites W2056711756 @default.
• W4383105087 cites W2060744329 @default.
• W4383105087 cites W2064906297 @default.
• W4383105087 cites W2089227776 @default.
• W4383105087 cites W2114499607 @default.
• W4383105087 cites W2118087548 @default.
• W4383105087 cites W2140409722 @default.
• W4383105087 cites W2171758504 @default.
• W4383105087 cites W2195587245 @default.
• W4383105087 cites W2460372346 @default.
• W4383105087 cites W2563045264 @default.
• W4383105087 cites W2576070094 @default.
• W4383105087 cites W2596555436 @default.
• W4383105087 cites W2731442884 @default.
• W4383105087 cites W2737043580 @default.
• W4383105087 cites W2746672093 @default.
• W4383105087 cites W2774278044 @default.
• W4383105087 cites W2798709656 @default.
• W4383105087 cites W2941184981 @default.
• W4383105087 cites W2962887615 @default.
• W4383105087 cites W2971696841 @default.
• W4383105087 cites W3048036301 @default.
• W4383105087 cites W3111541355 @default.
• W4383105087 cites W4221137705 @default.
• W4383105087 cites W4285725625 @default.
• W4383105087 cites W4287306928 @default.
• W4383105087 cites W4291021602 @default.
• W4383105087 cites W4311100509 @default.
• W4383105087 cites W4316686750 @default.
• W4383105087 cites W4360600134 @default.
• W4383105087 doi "https://doi.org/10.3389/fnagi.2023.1155630" @default.
• W4383105087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37469955" @default.
• W4383105087 hasPublicationYear "2023" @default.
• W4383105087 type Work @default.
• W4383105087 citedByCount "1" @default.
• W4383105087 crossrefType "journal-article" @default.
• W4383105087 hasAuthorship W4383105087A5011494156 @default.
• W4383105087 hasAuthorship W4383105087A5012270381 @default.
• W4383105087 hasAuthorship W4383105087A5018328570 @default.
• W4383105087 hasAuthorship W4383105087A5019154875 @default.
• W4383105087 hasAuthorship W4383105087A5023735744 @default.
• W4383105087 hasAuthorship W4383105087A5035406667 @default.
• W4383105087 hasAuthorship W4383105087A5037022895 @default.
• W4383105087 hasAuthorship W4383105087A5037964900 @default.
• W4383105087 hasAuthorship W4383105087A5050249978 @default.
• W4383105087 hasAuthorship W4383105087A5079568106 @default.
• W4383105087 hasAuthorship W4383105087A5092396675 @default.
• W4383105087 hasAuthorship W4383105087A5092396676 @default.
• W4383105087 hasBestOaLocation W43831050871 @default.
• W4383105087 hasConcept C104317684 @default.
• W4383105087 hasConcept C11960822 @default.
• W4383105087 hasConcept C134018914 @default.
• W4383105087 hasConcept C153911025 @default.
• W4383105087 hasConcept C184235292 @default.
• W4383105087 hasConcept C185592680 @default.
• W4383105087 hasConcept C2776415932 @default.
• W4383105087 hasConcept C28406088 @default.
• W4383105087 hasConcept C55493867 @default.
• W4383105087 hasConcept C57074206 @default.
• W4383105087 hasConcept C62478195 @default.
• W4383105087 hasConcept C86803240 @default.
• W4383105087 hasConcept C95444343 @default.
• W4383105087 hasConceptScore W4383105087C104317684 @default.
• W4383105087 hasConceptScore W4383105087C11960822 @default.
• W4383105087 hasConceptScore W4383105087C134018914 @default.
• W4383105087 hasConceptScore W4383105087C153911025 @default.
• W4383105087 hasConceptScore W4383105087C184235292 @default.
• W4383105087 hasConceptScore W4383105087C185592680 @default.
• W4383105087 hasConceptScore W4383105087C2776415932 @default.
• W4383105087 hasConceptScore W4383105087C28406088 @default.
• W4383105087 hasConceptScore W4383105087C55493867 @default.
• W4383105087 hasConceptScore W4383105087C57074206 @default.
• W4383105087 hasConceptScore W4383105087C62478195 @default.
• W4383105087 hasConceptScore W4383105087C86803240 @default.
• W4383105087 hasConceptScore W4383105087C95444343 @default.
• W4383105087 hasFunder F4320332161 @default.
• W4383105087 hasLocation W43831050871 @default.

• next